Apodex to Provide Freely Accessible AI Services for Drug Research Advancement#USA#Redwood_City#Clinical_Trials#Apodex#AI_Drug_Research
Apodex to Provide Freely Accessible AI Services for Drug Research Advancement
Apodex has launched complimentary AI services aimed at assisting small and mid-sized biotech companies in drug research. The initiative facilitates faster treatment evaluations.
third-news.com
October 8, 2026 at 5:33 PM
Apodex to Provide Freely Accessible AI Services for Drug Research Advancement#USA#Redwood_City#Clinical_Trials#Apodex#AI_Drug_Research